17,807 Shares in Revvity Inc. (NYSE:RVTY) Bought by Teacher Retirement System of Texas

Teacher Retirement System of Texas acquired a new position in Revvity Inc. (NYSE:RVTY - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 17,807 shares of the company's stock, valued at approximately $1,884,000.

Several other large investors also recently added to or reduced their stakes in the company. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in Revvity by 2.4% in the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,458 shares of the company's stock worth $1,424,000 after purchasing an additional 310 shares during the period. Amalgamated Bank boosted its stake in Revvity by 1.0% in the 1st quarter. Amalgamated Bank now owns 23,777 shares of the company's stock worth $2,516,000 after purchasing an additional 227 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Revvity by 11.1% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 13,415 shares of the company's stock valued at $1,417,000 after acquiring an additional 1,343 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in shares of Revvity by 7.7% during the 1st quarter. Sequoia Financial Advisors LLC now owns 27,921 shares of the company's stock valued at $2,954,000 after acquiring an additional 1,992 shares during the last quarter. Finally, Asset Management One Co. Ltd. boosted its position in shares of Revvity by 4.4% during the 1st quarter. Asset Management One Co. Ltd. now owns 50,725 shares of the company's stock valued at $5,367,000 after acquiring an additional 2,130 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Trading Down 2.9%

RVTY stock traded down $2.99 during midday trading on Monday, hitting $98.51. The company had a trading volume of 1,138,648 shares, compared to its average volume of 974,284. The company has a current ratio of 3.58, a quick ratio of 2.99 and a debt-to-equity ratio of 0.41. Revvity Inc. has a 52 week low of $87.70 and a 52 week high of $129.50. The stock's 50 day moving average price is $94.83 and its 200 day moving average price is $104.33. The stock has a market cap of $11.61 billion, a price-to-earnings ratio of 41.92, a PEG ratio of 2.56 and a beta of 0.98.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The firm had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. During the same quarter in the previous year, the company posted $0.98 earnings per share. The business's revenue was up 2.3% on a year-over-year basis. As a group, equities research analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.28%. Revvity's dividend payout ratio (DPR) is presently 11.91%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on RVTY. Barclays dropped their price target on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Raymond James Financial reiterated an "outperform" rating and set a $120.00 price target (down previously from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and dropped their price target for the company from $145.00 to $115.00 in a research report on Thursday, May 1st. Wall Street Zen upgraded Revvity from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Finally, Bank of America dropped their price target on Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $123.07.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.